1261286-13-8

Basic information

• Product Name: 4-(5,5,8,8-tetramethyl-3-nitro-5,6,7,8-tetrahydronaphthalen-2-ylamino)benzoic acid ethyl ester
• Synonyms: 4-(5,5,8,8-tetramethyl-3-nitro-5,6,7,8-tetrahydronaphthalen-2-ylamino)benzoic acid ethyl ester
• CAS NO: 1261286-13-8
• Molecular Weight: 396.486
• Mol File: 1261286-13-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-(5,5,8,8-tetramethyl-3-nitro-5,6,7,8-tetrahydronaphthalen-2-ylamino)benzoic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5,5,8,8-tetramethyl-3-nitro-5,6,7,8-tetrahydronaphthalen-2-ylamino)benzoic acid ethyl ester(1261286-13-8)
• EPA Substance Registry System: 4-(5,5,8,8-tetramethyl-3-nitro-5,6,7,8-tetrahydronaphthalen-2-ylamino)benzoic acid ethyl ester(1261286-13-8)

Safety Data

• Hazardous Substances Data: 1261286-13-8(Hazardous Substances Data)

Upstream product

• 122284-35-9 5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-3-nitro-naphth-2-ol 
• 22824-31-3 5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-ol 
• 1373429-19-6 trifluoromethanesulfonic acid 5,5,8,8-tetramethyl-3-nitro-5,6,7,8-tetrahydronaphthalen-2-yl ester 
• 94-09-7 p-aminoethylbenzoate 
• 102121-55-1 1,1,4,4-tetramethyl-6-nitro-1,2,3,4-tetrahydro-naphthalene 
• 92050-16-3 5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylamine 
• 51934-41-9 4-iodobenzoic acid ethyl ester 
• 155877-70-6 5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-nitro-2-naphthylamine 
• 6683-46-1 1,1,4,4-Tetramethyl-1,2,3,4-tetrahydro-naphthalene 

Downstream Products

• 1261286-14-9 C₃₀H₃₅BrN₂O₂ 
• 1261286-15-0 C₃₀H₃₄N₂O₂ 
• 1261286-10-5 C₂₈H₃₀N₂O₂ 
• 1261286-20-7 C₃₁H₃₆N₂O₂ 
• 1261286-11-6 C₂₉H₃₂N₂O₂ 
• 1261286-19-4 C₃₀H₃₃BrN₂O₄ 
• 1373429-28-7 4-(2,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphtho[2,3-d]imidazol-1-yl)benzoic acid ethyl ester 
• 1373429-30-1 4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphtho[2,3-d][1,2,3]triazol-1-yl)benzoic acid ethyl ester 
• 1373429-17-4 4-(2,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphtho[2,3-d]imidazol-1-yl)-benzoic acid 
• 1373429-31-2 4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphtho[2,3-d][1,2,3]triazol-1-yl)benzoic acid 

Relevant articles and documents

RXR partial agonist CBt-PMN exerts therapeutic effects on type 2 diabetes without the side effects of RXR full agonists

Treating insulin resistance and type 2 diabetes in rodents, currently known retinoid X receptor (RXR) agonists induce significant adverse effects. Here we introduce a novel RXR partial agonist CBt-PMN (11b), which shows a potent glucose-lowering effect and improvements of insulin secretion and glucose tolerance without the serious adverse effects caused by RXR full agonists. We suggest that RXR partial agonists may be a new class of antitype 2 diabetes drug candidates.